Corporate Criminal Liability can arise even when investigators have not yet identified or charged the individual employee whose conduct is attributed to a company, the Supreme Court has ruled. In Sanofi India Ltd v Central Bureau of Investigation, a two-judge bench dismissed Sanofi India’s attempt to end a criminal case at the threshold and set out a transaction-specific, three-stage attribution test.
What the Corporate Criminal Liability ruling says
The corporate criminal liability ruling separates two questions that are often blurred together. One is whether a corporation can be prosecuted at all for an offence framed in terms of imprisonment or dishonest intent. The other is whose acts and state of mind can legally count as the company’s own. The Court said Indian law does not give companies immunity merely because they are artificial persons.
Where imprisonment and a fine are prescribed, a court can impose the fine on a convicted corporation even though the company cannot physically be jailed. Where mens rea is required, the prosecution still has to prove the necessary guilty mind. It does that through attribution: identifying a human act and state of mind that the law treats as the corporation’s for the transaction in question.
The judgment stresses that attribution is not automatic vicarious liability. A company is not made criminally responsible for every employee’s action. The inquiry depends on the language and purpose of the offence, the internal authority attached to the act, and the facts that connect the individual’s conduct to the company. Those questions normally require evidence and therefore usually belong at trial, not in an early quashing petition.
The three-stage attribution framework
At stage one, the court examines the legislation creating the offence. Some statutes expressly identify a particular office-holder or make the corporation directly responsible for a duty. If the text supplies the attribution rule, that rule controls. This keeps the inquiry anchored to Parliament’s words rather than to a free-standing theory of who is senior enough.
At stage two, where the statute is silent, the court asks whether the company’s constitution, governance documents or delegation of authority identifies the person entrusted with the relevant function. The focus remains narrow: authority for the transaction or conduct in issue, not the most powerful person in the organisation as an abstract matter.
At stage three, if neither the statute nor the corporate constitution resolves attribution, the court identifies the person whose conduct and mental state should count as the company’s to fulfil the purpose of the offence. The Court described this final stage as flexible but transaction-specific. It is not a licence to presume guilt; the prosecution must establish the factual connection.
Why Sanofi India’s appeal failed
The case arose from supplies of pharmaceutical products for the Rare Materials Project at the Bhabha Atomic Research Centre in 2011–12, 2013–14 and 2015–16. The CBI alleged a conspiracy involving a BARC scientific officer and pharmaceutical suppliers to procure medicines at inflated rates and beyond requirements. Sanofi India was charged, but no employee or officer of the company was arraigned as an accused.
Sanofi India argued that offences involving mens rea could not proceed against the corporate entity without a named natural person. The Karnataka High Court declined to quash the proceedings in 2019. The Supreme Court has now dismissed the company’s appeal, holding that non-identification and non-arraignment of an employee do not create a categorical bar at the quashing stage.
This procedural point matters. The Supreme Court did not decide that the allegations are true, and it did not declare Sanofi India guilty. It held that the record contained enough material for the prosecution to continue and that attribution should be tested systematically with evidence. The presumption of innocence remains intact.
| Item | Verified detail |
|---|---|
| Case | Sanofi India Ltd v Central Bureau of Investigation |
| Citation | 2026 INSC 957 |
| Bench | Justices J B Pardiwala and Manoj Misra |
| Decision date | September 7, 2026 |
| Appeal | Criminal Appeal No. 4250 of 2026 |
| Outcome | Appeal dismissed; proceedings not quashed |
What changes for companies and investigators
For companies, the immediate consequence is that an early challenge cannot rest only on the absence of a named officer. Boards and legal teams will need to map who controlled the relevant transaction, what authority was delegated, what records show, and how the applicable offence is framed. Governance charts alone may not answer a transaction-specific attribution question.
For investigators, the ruling removes a threshold shortcut for corporate defendants, but it does not remove the burden of proof. Prosecutors still need evidence of the act, the required mental state and the basis for treating that state as the corporation’s. The Court expressly resisted an abstract “directing mind” label that would turn seniority into a universal answer.
The framework also keeps individual liability separate. Attribution operates from the natural person to the corporation for deciding corporate responsibility; it does not determine whether that person is individually guilty. A trial court may therefore face distinct questions about the company and any human accused.
Why the ruling matters beyond one prosecution
The Court asked its Registry to send the judgment to all High Courts, signalling that the framework is intended to guide a recurring problem. Corporate prosecutions arise across anti-corruption, fraud, environmental, tax and economic laws. A common attribution method can reduce contradictory threshold decisions while leaving room for each statute’s design.
The business consequence is less about one company’s immediate financial exposure than about evidence architecture. Organisations with clear delegations, approval trails, vendor controls and escalation records will be better placed to explain who had authority and how a questioned decision was made. Weak records can make the attribution inquiry harder even before guilt is considered.
The judgment also fits a broader compliance environment in which Indian regulators are testing governance systems, not merely end results. Recent Lapaas Voice coverage of NSE’s revised auction controls and SEBI’s angel-fund transition deadline shows the same operational theme: regulated entities must be able to demonstrate how responsibilities are assigned and monitored.
In plain terms, the Supreme Court’s corporate criminal liability ruling means a company cannot end a mens rea prosecution merely by pointing out that no employee was named in the charge sheet; the prosecution must still prove whose conduct is attributable to the company and why.
What to watch next
The immediate next step is the underlying criminal proceeding, where the prosecution’s evidence will be tested. Courts applying the framework will also have to decide how deeply to examine delegations and statutory purpose in different industries. The judgment itself cautions that its broad test does not resolve every possible attribution dispute.
Companies should not read the decision as a presumption against them. Its practical instruction is narrower: corporate personality does not create automatic immunity, and attribution is a factual legal inquiry. The quality of contemporaneous records, the exact offence and the specific transaction will decide how the framework operates.
The official judgment also explains why the prosecution could not be stopped merely because the charge sheet did not array a Sanofi employee. At the quashing stage, the court was not conducting the evidence-heavy exercise required to identify the particular person whose state of mind could be attributed to the company. That exercise depends on the offence, the transaction and the allocation of authority revealed by the record. The bench therefore rejected a categorical rule that would make the individual’s prior prosecution a condition for trying the corporation.
For compliance teams, the distinction between formal position and functional authority deserves special attention. A board resolution, delegation matrix, approval email or operating procedure may show who controlled the relevant act more accurately than an organisation chart. The judgment’s transaction-specific approach makes preservation of those records especially important. It also means a company may challenge attribution at trial with evidence showing that the alleged actor lacked the authority or connection the prosecution claims.
The ruling remains procedural at this point. Dismissal of the appeal allows the criminal case to continue; it does not establish the alleged conspiracy, the amount of any loss or the guilt of Sanofi India or any natural person. Those propositions must still be proved under the ordinary criminal standard, and the company retains its defences on facts and law.
Frequently asked questions
Did the Supreme Court convict Sanofi India?
No. It dismissed an appeal seeking to quash the proceedings. Guilt, the truth of the allegations and the final attribution of any person’s conduct remain matters for the trial process.
Can a company be prosecuted when an offence carries imprisonment?
Yes. The Court reaffirmed that the impossibility of imprisoning a corporation does not create immunity; where the provision also prescribes a fine, that punishment can apply to the company.
Must investigators identify a director before charging a company?
Not in every case. The judgment says the relevant person may not hold a formal senior title, and failure to identify or arraign an individual is not by itself enough to quash the corporate case.
Sources: Supreme Court of India judgment; Bar & Bench; LiveLaw; Times of India; The Law Daily.
Get the day’s top stories in your inbox
One concise email. No spam, unsubscribe anytime.
